Repository landing page
Validation of common DEGs in BEAS-C and derivatives cells treated with pharmacological inhibitors of the PI3K/AKT pathway.
Abstract
<p><b>A)</b> Analysis of 7 common DEGs enriched in BioFunctions in BEAS-C and derivatives. Bars are mean±SD of 3 independent experiments performed in triplicate. Statistical analysis was performed by One-way ANOVA test and Dunnett's test for each gene. p-values were indicated in the figure. <b>B)</b> BEAS-C cells and derivatives were treated for 24 hours with the indicated doses of LY294002. Graphs show mRNA levels of the indicated genes in BEAS-C cells and derivatives. Bars are mean±SD of 3 independent experiments conducted in triplicate. Statistical analysis was performed by <i>t-</i>test. p-values as indicated in the figure.</p- Image
- Figure
- Biochemistry
- Medicine
- Microbiology
- Cell Biology
- Genetics
- Molecular Biology
- Physiology
- Pharmacology
- Immunology
- Developmental Biology
- Cancer
- Hematology
- Infectious Diseases
- Plant Biology
- Chemical Sciences not elsewhere classified
- RT-PCR
- lung cancer Hyperactivation
- 1A
- PIK 3CA
- CTSZ
- S 473 phosphorylation
- IPA
- CCND
- DEG
- up-regulated
- PI 3K
- PTGES
- PTEN loss
- -2B
- EMP
- PI 3K pathway
- Specific gene expression signatures
- MK
- CDK
- NSCLC cell lines
- ATF
- CDKN
- PEG
- down-regulated
- HBEGF
- AKT 1
- IGFBP
- lung cancer cells
- TRIB
- BEAS-C
- ASNS
- GDF
- FHL
- Ingenuity Pathway Analysis
- constitutive PI 3K
- BEAS-AKT 1-E BEAS-PIK 3CA
- SGK
- lung epithelial cells
- LY
- LCN
- TGFBR
- analysis
- 100P